Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 8219287, 11 pages
http://dx.doi.org/10.1155/2016/8219287
Research Article

Glycyrrhizic Acid Attenuates Sepsis-Induced Acute Kidney Injury by Inhibiting NF-κB Signaling Pathway

Department of Emergency Medicine, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang 110004, China

Received 17 April 2015; Accepted 5 July 2015

Academic Editor: José L. Ríos

Copyright © 2016 Hongyu Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. E. Fry, “Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues,” American Surgeon, vol. 78, no. 1, pp. 1–8, 2012. View at Google Scholar · View at Scopus
  2. P. S. Tipler, J. Pamplin, V. Mysliwiec, D. Anderson, and C. A. Mount, “Use of a protocolized approach to the management of sepsis can improve time to first dose of antibiotics,” Journal of Critical Care, vol. 28, no. 2, pp. 148–151, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Grozdanovski, Z. Milenkovic, I. Demiri, and K. Spasovska, “Prediction of outcome from community-acquired severe sepsis and septic shock in tertiary-care university hospital in a developing country,” Critical Care Research and Practice, vol. 2012, Article ID 182324, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. H. L. Cronshaw, R. Daniels, A. Bleetman, E. Joynes, and M. Sheils, “Impact of the surviving sepsis campaign on the recognition and management of severe sepsis in the emergency department: are we failing?” Emergency Medicine Journal, vol. 28, no. 8, pp. 670–675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. S. Hotchkiss, G. Monneret, and D. Payen, “Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach,” The Lancet Infectious Diseases, vol. 13, no. 3, pp. 260–268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Bagshaw, C. George, and R. Bellomo, “Early acute kidney injury and sepsis: a multicentre evaluation,” Critical Care, vol. 12, no. 2, article R47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Rajapakse, C. Rodrigo, A. Rajapakse, D. Kirthinanda, and S. Wijeratne, “Renal replacement therapy in sepsis-induced acute renal failure,” Saudi Journal of Kidney Diseases and Transplantation, vol. 20, no. 4, pp. 553–559, 2009. View at Google Scholar · View at Scopus
  8. L. Wu, N. Gokden, and P. R. Mayeux, “Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury,” Journal of the American Society of Nephrology, vol. 18, no. 6, pp. 1807–1815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Abe, T. Ebina, and N. Ishida, “Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice,” Microbiology and Immunology, vol. 26, no. 6, pp. 535–539, 1982. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Baba and S. Shigeta, “Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro,” Antiviral Research, vol. 7, no. 2, pp. 99–107, 1987. View at Publisher · View at Google Scholar · View at Scopus
  11. L. J. Ming and A. C. Y. Yin, “Therapeutic effects of glycyrrhizic acid,” Natural Product Communications, vol. 8, no. 3, pp. 415–418, 2013. View at Google Scholar · View at Scopus
  12. O. A. Pliasunova, T. V. Il'ina, I. Kiseleva et al., “The anti-HIV activity of glycyrrhizic acid penta-O-nicotinate,” Vestnik Rossiĭskoĭ Akademii Meditsinskikh Nauk, no. 11, pp. 42–46, 2004. View at Google Scholar
  13. Z. Y. Wang and D. W. Nixon, “Licorice and cancer,” Nutrition and Cancer, vol. 39, no. 1, pp. 1–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Arase, K. Ikeda, N. Murashima et al., “The long term efficacy of glycyrrhizin in chronic hepatitis C patients,” Cancer, vol. 79, no. 8, pp. 1494–1500, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. T. G. J. van Rossum, A. G. Vulto, W. C. J. Hop, and S. W. Schalm, “Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C,” American Journal of Gastroenterology, vol. 96, no. 8, pp. 2432–2437, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. K.-L. Li, J.-G. Zhang, H.-M. Wang, and J. Chen, “The effects of glycyrrhizin-18alpha on the expression of NF-kappaB in the renal interstitium of rats with obstructive nephropathy,” Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, vol. 20, no. 1, pp. 31–33, 2004. View at Google Scholar · View at Scopus
  17. S. Hou, F. Zheng, Y. Li, L. Gao, and J. Zhang, “The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose,” International Journal of Molecular Sciences, vol. 15, no. 9, pp. 15026–15043, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Bi, G. Zhu, Z. Han et al., “Protective effect of glycyrrhizin on nephrotic syndrome induced by adriamycin in rats,” Clinical and Investigative Medicine, vol. 32, no. 3, pp. E229–E238, 2009. View at Google Scholar · View at Scopus
  19. K. Doi, A. Leelahavanichkul, P. S. T. Yuen, and R. A. Star, “Animal models of sepsis and sepsis-induced kidney injury,” The Journal of Clinical Investigation, vol. 119, no. 10, pp. 2868–2878, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Miyaji, X. Hu, P. S. T. Yuen et al., “Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice,” Kidney International, vol. 64, no. 5, pp. 1620–1631, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Hilton, “Defining acute renal failure,” CMAJ, vol. 183, no. 10, pp. 1167–1169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. W. J. Hubbard, M. Choudhry, M. G. Schwacha et al., “Cecal ligation and puncture,” Shock, vol. 24, supplement 1, pp. 52–57, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. G. M. Chertow, E. Burdick, M. Honour, J. V. Bonventre, and D. W. Bates, “Acute kidney injury, mortality, length of stay, and costs in hospitalized patients,” Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3365–3370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Grenz, J.-H. Kim, J. D. Bauerle, E. Tak, H. K. Eltzschig, and E. T. Clambey, “Adora2b adenosine receptor signaling protects during acute kidney injury via inhibition of neutrophil-dependent TNF-α release,” Journal of Immunology, vol. 189, no. 9, pp. 4566–4573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-W. Lee, W.-J. Nam, M.-J. Han et al., “Role of IL-1alpha in cisplatin-induced acute renal failure in mice,” Korean Journal of Internal Medicine, vol. 26, no. 2, pp. 187–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. J. Lee, E. Borsting, A.-E. Declèves, P. Singh, and R. Cunard, “Podocytes express IL-6 and lipocalin 2/neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury,” Nephron—Experimental Nephrology, vol. 121, no. 3-4, pp. e86–e96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Heemskerk, R. Masereeuw, F. G. M. Russel, and P. Pickkers, “Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury,” Nature Reviews Nephrology, vol. 5, no. 11, pp. 629–640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Hauser, H. Bracht, M. Matejovic, P. Radermacher, and B. Venkatesh, “Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies,” Anesthesia and Analgesia, vol. 101, no. 2, pp. 488–498, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Tiwari, R. W. Brock, J. K. Megyesi, G. P. Kaushal, and P. R. Mayeux, “Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases,” The American Journal of Physiology—Renal Physiology, vol. 289, no. 6, pp. F1324–F1332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Heemskerk, P. Pickkers, M. P. W. J. M. Bouw et al., “Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 4, pp. 853–862, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. D. A. Kniss, “Cyclooxygenases in reproductive medicine and biology,” Journal of the Society for Gynecologic Investigation, vol. 6, no. 6, pp. 285–292, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. C. F. Nathan, “Secretory products of macrophages,” Journal of Clinical Investigation, vol. 79, no. 2, pp. 319–326, 1987. View at Publisher · View at Google Scholar · View at Scopus
  33. P. N. Cunningham, H. M. Dyanov, P. Park, J. Wang, K. A. Newell, and R. J. Quigg, “Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney,” Journal of Immunology, vol. 168, no. 11, pp. 5817–5823, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. S. K. Jo, D. R. Cha, W. Y. Cho et al., “Inflammatory cytokines and lipopolysaccharide induce fas-mediated apoptosis in renal tubular cells,” Nephron, vol. 91, no. 3, pp. 406–415, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Adams and S. Cory, “Life-or-death decisions by the Bcl-2 protein family,” Trends in Biochemical Sciences, vol. 26, no. 1, pp. 61–66, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Adamzik, S. Schäfer, U. H. Frey et al., “The NFKB1 promoter polymorphism (−94ins/delATTG) alters nuclear translocation of NF-κB1 in monocytes after lipopolysaccharide stimulation and is associated with increased mortality in sepsis,” Anesthesiology, vol. 118, no. 1, pp. 123–133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Xu, F. Cao, L. Liu et al., “Tanshinone IIA-induced attenuation of lung injury in endotoxemic mice is associated with reduction of hypoxia-inducible factor 1α expression,” American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 5, pp. 1028–1035, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Aosasa, S. Ono, H. Mochizuki, H. Tsujimoto, C. Ueno, and A. Matsumoto, “Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes,” Shock, vol. 15, no. 2, pp. 101–105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. Y.-J. Surh, K.-S. Chun, H.-H. Cha et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation,” Mutation Research, vol. 480-481, pp. 243–268, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Moriyuki, F. Sekiguchi, K. Matsubara, H. Nishikawa, and A. Kawabata, “Curcumin inhibits the proteinase-activated receptor-2-triggered prostaglandin E2 production by suppressing cyclooxygenase-2 upregulation and Akt-dependent activation of nuclear factor-κB in human lung epithelial cells,” Journal of Pharmacological Sciences, vol. 114, no. 2, pp. 225–229, 2010. View at Publisher · View at Google Scholar · View at Scopus